| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vasoconstrictor Agents | 6 | 2017 | 714 | 1.39 | Why? |
| Network Meta-Analysis | 7 | 2020 | 426 | 1.34 | Why? |
| Adrenal Cortex Hormones | 18 | 2021 | 6537 | 1.20 | Why? |
| Sepsis | 12 | 2021 | 3517 | 1.09 | Why? |
| Shock, Traumatic | 2 | 2017 | 18 | 0.87 | Why? |
| Idiopathic Pulmonary Fibrosis | 3 | 2017 | 595 | 0.86 | Why? |
| Fournier Gangrene | 1 | 2020 | 19 | 0.86 | Why? |
| Shock, Septic | 8 | 2018 | 1313 | 0.85 | Why? |
| Fluid Therapy | 6 | 2018 | 628 | 0.81 | Why? |
| Hypotension | 3 | 2017 | 392 | 0.77 | Why? |
| Adrenal Insufficiency | 6 | 2018 | 190 | 0.74 | Why? |
| Spinal Puncture | 1 | 2018 | 95 | 0.70 | Why? |
| Needles | 1 | 2018 | 87 | 0.70 | Why? |
| Critical Illness | 21 | 2021 | 17281 | 0.67 | Why? |
| Clonidine | 1 | 2017 | 31 | 0.67 | Why? |
| Diphosphonates | 1 | 2017 | 121 | 0.62 | Why? |
| Hydrocortisone | 6 | 2020 | 1790 | 0.62 | Why? |
| Critical Care | 19 | 2019 | 14081 | 0.61 | Why? |
| Sodium Chloride | 1 | 2017 | 203 | 0.60 | Why? |
| Free Radical Scavengers | 1 | 2016 | 82 | 0.60 | Why? |
| Hypnotics and Sedatives | 2 | 2020 | 624 | 0.58 | Why? |
| Tissue and Organ Procurement | 4 | 2018 | 1277 | 0.58 | Why? |
| Randomized Controlled Trials as Topic | 13 | 2021 | 10649 | 0.57 | Why? |
| Practice Guidelines as Topic | 16 | 2020 | 15421 | 0.55 | Why? |
| Ischemic Attack, Transient | 1 | 2018 | 439 | 0.55 | Why? |
| Acetylcysteine | 1 | 2016 | 255 | 0.50 | Why? |
| Research Design | 5 | 2021 | 5830 | 0.45 | Why? |
| Platelet Aggregation Inhibitors | 2 | 2019 | 1671 | 0.44 | Why? |
| Deep Sedation | 4 | 2018 | 121 | 0.42 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.41 | Why? |
| Pyridones | 1 | 2016 | 738 | 0.40 | Why? |
| Respiratory Insufficiency | 4 | 2021 | 7301 | 0.40 | Why? |
| Psychomotor Agitation | 4 | 2018 | 208 | 0.40 | Why? |
| Patient Positioning | 1 | 2020 | 1505 | 0.39 | Why? |
| Conscious Sedation | 4 | 2018 | 222 | 0.39 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.39 | Why? |
| Pituitary-Adrenal System | 3 | 2017 | 135 | 0.37 | Why? |
| Noninvasive Ventilation | 2 | 2019 | 2329 | 0.35 | Why? |
| Respiration, Artificial | 13 | 2021 | 22116 | 0.34 | Why? |
| Indoles | 1 | 2016 | 1243 | 0.33 | Why? |
| Intensive Care Units | 19 | 2021 | 29594 | 0.33 | Why? |
| Blood Pressure | 2 | 2017 | 2198 | 0.32 | Why? |
| Extracorporeal Membrane Oxygenation | 3 | 2021 | 5002 | 0.31 | Why? |
| Restraint, Physical | 4 | 2018 | 74 | 0.31 | Why? |
| Organ Dysfunction Scores | 5 | 2021 | 1475 | 0.31 | Why? |
| Evidence-Based Medicine | 8 | 2020 | 3228 | 0.31 | Why? |
| Humans | 97 | 2021 | 930598 | 0.30 | Why? |
| Conflict of Interest | 2 | 2018 | 175 | 0.30 | Why? |
| Clinical Decision-Making | 2 | 2021 | 3755 | 0.29 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2021 | 9335 | 0.28 | Why? |
| Death | 2 | 2018 | 334 | 0.28 | Why? |
| Pain Management | 5 | 2020 | 854 | 0.27 | Why? |
| Canada | 9 | 2021 | 6018 | 0.27 | Why? |
| Tissue Donors | 3 | 2018 | 1679 | 0.26 | Why? |
| Organ Transplantation | 2 | 2018 | 2616 | 0.26 | Why? |
| Adenosine Monophosphate | 2 | 2020 | 5652 | 0.26 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.26 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.25 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.25 | Why? |
| Treatment Outcome | 15 | 2021 | 51732 | 0.24 | Why? |
| Anticoagulants | 3 | 2018 | 9563 | 0.24 | Why? |
| Advisory Committees | 6 | 2018 | 1418 | 0.23 | Why? |
| Delirium | 4 | 2018 | 1061 | 0.22 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.22 | Why? |
| Length of Stay | 5 | 2020 | 11042 | 0.21 | Why? |
| Scrotum | 1 | 2020 | 48 | 0.21 | Why? |
| Pain | 2 | 2018 | 1084 | 0.21 | Why? |
| Venous Thromboembolism | 1 | 2018 | 4273 | 0.20 | Why? |
| Carrageenan | 1 | 2021 | 123 | 0.20 | Why? |
| Sleep Wake Disorders | 4 | 2018 | 1463 | 0.20 | Why? |
| Penis | 1 | 2020 | 101 | 0.20 | Why? |
| Anti-Bacterial Agents | 3 | 2020 | 10083 | 0.20 | Why? |
| Respiratory Distress Syndrome, Newborn | 1 | 2020 | 124 | 0.19 | Why? |
| Chemoprevention | 2 | 2021 | 585 | 0.19 | Why? |
| Epidemiologic Studies | 1 | 2021 | 554 | 0.19 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.19 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.18 | Why? |
| Pandemics | 20 | 2021 | 389249 | 0.18 | Why? |
| Chlorine | 1 | 2018 | 55 | 0.18 | Why? |
| Fasciitis, Necrotizing | 1 | 2019 | 56 | 0.18 | Why? |
| Betacoronavirus | 12 | 2020 | 204454 | 0.18 | Why? |
| Post-Dural Puncture Headache | 1 | 2018 | 33 | 0.18 | Why? |
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2017 | 17 | 0.18 | Why? |
| Erythrocyte Transfusion | 2 | 2019 | 386 | 0.18 | Why? |
| Intracranial Hypertension | 1 | 2019 | 111 | 0.18 | Why? |
| Analgesia | 1 | 2020 | 211 | 0.17 | Why? |
| Electrolytes | 1 | 2018 | 103 | 0.17 | Why? |
| Resuscitation | 3 | 2017 | 638 | 0.17 | Why? |
| Platelet Transfusion | 1 | 2019 | 209 | 0.17 | Why? |
| Soft Tissue Infections | 1 | 2019 | 116 | 0.17 | Why? |
| Hospital Rapid Response Team | 1 | 2018 | 100 | 0.16 | Why? |
| Frailty | 2 | 2019 | 1432 | 0.16 | Why? |
| Glucocorticoids | 3 | 2021 | 4431 | 0.16 | Why? |
| Hospital Mortality | 9 | 2021 | 22087 | 0.16 | Why? |
| Shock, Hemorrhagic | 1 | 2017 | 81 | 0.16 | Why? |
| Guideline Adherence | 2 | 2020 | 2309 | 0.16 | Why? |
| Hypothalamo-Hypophyseal System | 1 | 2017 | 187 | 0.16 | Why? |
| Physical Examination | 2 | 2019 | 755 | 0.15 | Why? |
| World Health Organization | 4 | 2021 | 4213 | 0.15 | Why? |
| Neuromuscular Blocking Agents | 1 | 2017 | 121 | 0.15 | Why? |
| Albumins | 1 | 2018 | 324 | 0.15 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.14 | Why? |
| Anti-Inflammatory Agents | 3 | 2020 | 6153 | 0.14 | Why? |
| Epinephrine | 1 | 2017 | 323 | 0.14 | Why? |
| Positive-Pressure Respiration | 2 | 2021 | 1160 | 0.14 | Why? |
| Vitamin K | 1 | 2017 | 263 | 0.14 | Why? |
| Shock | 2 | 2020 | 1868 | 0.13 | Why? |
| Lactic Acid | 1 | 2017 | 393 | 0.13 | Why? |
| Hydroxychloroquine | 4 | 2021 | 12447 | 0.13 | Why? |
| Mentors | 1 | 2017 | 372 | 0.13 | Why? |
| Disclosure | 1 | 2018 | 423 | 0.13 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.13 | Why? |
| Pilot Projects | 4 | 2019 | 5182 | 0.13 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.13 | Why? |
| Time Factors | 5 | 2020 | 31397 | 0.13 | Why? |
| Receptors, Interleukin-6 | 1 | 2021 | 1383 | 0.12 | Why? |
| Antiviral Agents | 3 | 2020 | 41703 | 0.12 | Why? |
| Coronary Artery Bypass | 1 | 2019 | 629 | 0.12 | Why? |
| Informed Consent | 2 | 2017 | 890 | 0.12 | Why? |
| Pulmonary Medicine | 1 | 2019 | 706 | 0.12 | Why? |
| Severity of Illness Index | 8 | 2020 | 48226 | 0.12 | Why? |
| Geriatric Assessment | 2 | 2019 | 1372 | 0.12 | Why? |
| Proton Pump Inhibitors | 1 | 2017 | 377 | 0.12 | Why? |
| Ontario | 4 | 2019 | 1966 | 0.11 | Why? |
| Adult | 17 | 2021 | 244371 | 0.11 | Why? |
| Brain Injuries | 1 | 2017 | 374 | 0.11 | Why? |
| Ivermectin | 1 | 2021 | 973 | 0.11 | Why? |
| Quality of Life | 3 | 2017 | 9820 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.11 | Why? |
| Renal Replacement Therapy | 2 | 2017 | 1530 | 0.11 | Why? |
| Troponin I | 1 | 2019 | 1298 | 0.10 | Why? |
| Public Opinion | 1 | 2020 | 1165 | 0.10 | Why? |
| Diagnostic Imaging | 1 | 2019 | 1044 | 0.10 | Why? |
| Aerosols | 3 | 2021 | 5393 | 0.10 | Why? |
| Patient Preference | 1 | 2017 | 750 | 0.10 | Why? |
| Bayes Theorem | 2 | 2018 | 3237 | 0.10 | Why? |
| Lopinavir | 2 | 2021 | 4308 | 0.10 | Why? |
| Clostridium Infections | 1 | 2017 | 595 | 0.10 | Why? |
| Heart Injuries | 1 | 2016 | 608 | 0.10 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2018 | 1731 | 0.10 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2017 | 861 | 0.10 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.09 | Why? |
| Prone Position | 1 | 2020 | 1861 | 0.09 | Why? |
| Self Report | 1 | 2020 | 3802 | 0.09 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.09 | Why? |
| Logistic Models | 3 | 2018 | 9089 | 0.09 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.09 | Why? |
| Biomedical Research | 2 | 2018 | 5270 | 0.09 | Why? |
| Breast Feeding | 1 | 2018 | 1585 | 0.09 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.08 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.08 | Why? |
| Research Personnel | 1 | 2017 | 1037 | 0.08 | Why? |
| Systemic Inflammatory Response Syndrome | 5 | 2018 | 6653 | 0.08 | Why? |
| Attitude to Health | 1 | 2020 | 2002 | 0.08 | Why? |
| Fibrinolytic Agents | 1 | 2018 | 1702 | 0.08 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.08 | Why? |
| Female | 19 | 2021 | 380317 | 0.08 | Why? |
| Male | 18 | 2021 | 367725 | 0.08 | Why? |
| Prospective Studies | 8 | 2019 | 43301 | 0.08 | Why? |
| Pulmonary Fibrosis | 1 | 2017 | 1068 | 0.08 | Why? |
| Receptors, Glucocorticoid | 2 | 2017 | 118 | 0.08 | Why? |
| Survivors | 1 | 2019 | 2619 | 0.08 | Why? |
| Information Dissemination | 2 | 2020 | 2986 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Decision Making | 2 | 2019 | 3132 | 0.08 | Why? |
| APACHE | 2 | 2018 | 682 | 0.07 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 2426 | 0.07 | Why? |
| Reproducibility of Results | 5 | 2019 | 11304 | 0.07 | Why? |
| Emergency Service, Hospital | 3 | 2018 | 14232 | 0.07 | Why? |
| Electrocardiography | 1 | 2019 | 3957 | 0.07 | Why? |
| Aged | 13 | 2021 | 215776 | 0.07 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.07 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.07 | Why? |
| Feasibility Studies | 3 | 2019 | 3467 | 0.07 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.06 | Why? |
| Infant, Newborn | 3 | 2020 | 23105 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2019 | 3361 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Guidelines as Topic | 3 | 2020 | 2844 | 0.06 | Why? |
| Health Behavior | 1 | 2020 | 4449 | 0.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3832 | 0.06 | Why? |
| Disease Progression | 2 | 2019 | 13580 | 0.06 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.06 | Why? |
| Observational Studies as Topic | 2 | 2019 | 1887 | 0.05 | Why? |
| Uncertainty | 2 | 2021 | 1888 | 0.05 | Why? |
| Pregnancy | 2 | 2020 | 23879 | 0.05 | Why? |
| Saphenous Vein | 1 | 2019 | 67 | 0.05 | Why? |
| Television | 1 | 2020 | 224 | 0.05 | Why? |
| Neuroendocrine Cells | 1 | 2017 | 9 | 0.05 | Why? |
| Infant | 2 | 2018 | 30274 | 0.05 | Why? |
| Ultrasonography, Doppler, Transcranial | 1 | 2019 | 143 | 0.05 | Why? |
| Cosyntropin | 1 | 2017 | 9 | 0.05 | Why? |
| Hypercapnia | 1 | 2019 | 172 | 0.04 | Why? |
| Transplantation, Autologous | 1 | 2019 | 364 | 0.04 | Why? |
| Hormones | 1 | 2017 | 66 | 0.04 | Why? |
| Adrenocorticotropic Hormone | 1 | 2017 | 107 | 0.04 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2020 | 1256 | 0.04 | Why? |
| Immunosuppressive Agents | 1 | 2016 | 6331 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Stomach Ulcer | 1 | 2017 | 101 | 0.04 | Why? |
| Observer Variation | 1 | 2019 | 622 | 0.04 | Why? |
| Social Values | 1 | 2017 | 109 | 0.04 | Why? |
| Transplantation, Homologous | 1 | 2019 | 757 | 0.04 | Why? |
| Walk Test | 1 | 2019 | 461 | 0.04 | Why? |
| Organizational Policy | 1 | 2021 | 694 | 0.04 | Why? |
| Group Processes | 1 | 2017 | 210 | 0.04 | Why? |
| Arterial Pressure | 1 | 2017 | 208 | 0.04 | Why? |
| Mental Competency | 1 | 2016 | 128 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.04 | Why? |
| Research Report | 1 | 2019 | 376 | 0.04 | Why? |
| Wounds and Injuries | 2 | 2018 | 1708 | 0.03 | Why? |
| Cannula | 1 | 2020 | 750 | 0.03 | Why? |
| Child | 3 | 2018 | 70012 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Visitors to Patients | 1 | 2021 | 671 | 0.03 | Why? |
| Single-Blind Method | 1 | 2018 | 1283 | 0.03 | Why? |
| Clinical Deterioration | 1 | 2018 | 473 | 0.03 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Stress, Physiological | 1 | 2017 | 378 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.03 | Why? |
| Policy | 1 | 2021 | 1372 | 0.03 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.03 | Why? |
| Nutrition Assessment | 1 | 2017 | 527 | 0.03 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.03 | Why? |
| Nutritional Support | 1 | 2017 | 447 | 0.03 | Why? |
| Patient Care Planning | 1 | 2017 | 582 | 0.03 | Why? |
| Withholding Treatment | 1 | 2017 | 798 | 0.03 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2017 | 669 | 0.03 | Why? |
| Signal Transduction | 2 | 2017 | 7207 | 0.03 | Why? |
| Prognosis | 3 | 2019 | 32490 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.03 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.03 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2019 | 4260 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2021 | 1766 | 0.02 | Why? |
| Registries | 2 | 2019 | 12327 | 0.02 | Why? |
| Home Care Services | 1 | 2019 | 1351 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Terminal Care | 1 | 2017 | 928 | 0.02 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.02 | Why? |
| Methylprednisolone | 1 | 2017 | 2107 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Patient Selection | 1 | 2021 | 4560 | 0.02 | Why? |
| Saudi Arabia | 1 | 2017 | 4423 | 0.02 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2018 | 3088 | 0.02 | Why? |
| Ventilators, Mechanical | 1 | 2018 | 2193 | 0.02 | Why? |
| Survival Analysis | 1 | 2019 | 7592 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2019 | 2093 | 0.02 | Why? |
| Cardiac Surgical Procedures | 1 | 2019 | 1931 | 0.02 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Dyspnea | 1 | 2018 | 3847 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Coronary Artery Disease | 1 | 2019 | 2570 | 0.02 | Why? |
| Patient Discharge | 1 | 2019 | 5696 | 0.02 | Why? |
| Europe | 1 | 2019 | 12702 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.01 | Why? |
| Sex Factors | 1 | 2019 | 11014 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Social Media | 1 | 2020 | 5798 | 0.01 | Why? |
| Societies, Medical | 1 | 2015 | 6907 | 0.01 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.01 | Why? |
| Retrospective Studies | 2 | 2019 | 105322 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2019 | 25144 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.01 | Why? |